Skip to content
Journal Title Abbrev.
J. Elem.
ISSN – 1644-2296
DOI: 10.5601

Search article

Language
flag flag

Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation

Issue: 3/2020

Recevied: Mar 06, 2020

Accepted: May 16, 2020

Published: July 17, 2020

Authors:

Celik M., Guldiken S., Ayturk S., Yilmaz Bulbul B., Kucukarda A., Can N., Tastekin E., Sezer A., Sut N., Tugrul A., Gurkan H., Tozkir H., Demirkan B.

Categories: Biology and microbiology, Food science, Medicine and veterinary

DOI: 10.5601/jelem.2020.25.1.1984

Abstract:

    Iodine is an essential element for the production of thyroid hormones. In recent years, it has been suggested that excessive consumption of iodine may play a role in the pathogenesis of papillary thyroid cancer (PTC). In addition, studies have suggested that high iodine consumption is an important risk factor for the formation of a BRAF mutation in the thyroid gland. A prospectively designed study included 132 cases scheduled for thyroidectomy for various reasons. Urine iodine levels of all patients were examined before the operation. The iodine excretion levels of the patients were grouped according to the median urinary iodine concentration determined in community screenings (those with

Citation:

quote-mark
Celik M., Guldiken S., Salt S.A., Bulbul B.Y., Kucukarda A., Can N., Tastekin E., Sezer A., Sut N., Tugrul A., Gurkan H., Tozkir H., Demirkan B. 2020. Urine iodine excretion in patients with papillary thyroid cancer evaluation of the relationship with the presence of BRAF mutation. J. Elem., 25(3): 1019 - 1028. DOI: 10.5601/jelem.2020.25.1.1984

Keywords:

papillary thyroid cancer, BRAF mutation, urine iodine excretion

About issue:

25.3.2020
Download article
Jsite